文献速递痛风与晶体性关节病

低尿酸血症与美国普通人群死亡风险

Hypouricemia and Mortality Risk in the US General Population.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-07-12

基于NHANES 1988-1994和1999-2008数据,纳入41807名美国成人,分析血尿酸水平与全因及病因特异性死亡的关系。男性血尿酸<4 mg/dl者全因死亡风险升高28%(HR 1.28,95%CI 1.13-1.45),糖尿病相关死亡风险近乎三倍(HR 2.89,95%CI 1.59-5.23);女性血尿酸<3 mg/dl者未见死亡风险升高(HR 1.09,95%CI 0.92-1.28)。

要点

  • 男性血尿酸<4 mg/dl与全因死亡风险升高28%相关,糖尿病相关死亡风险近乎三倍。
  • 女性血尿酸低至<3 mg/dl未观察到长期超额死亡风险。
  • 男性低尿酸血症的全因死亡超额部分可能源于未控制高血糖的促尿酸排泄效应(反向因果)。

核心结论

  • 美国女性血尿酸低至<3 mg/dl无长期超额死亡风险,不支持低尿酸血症与女性早亡的因果关系。
  • 美国男性低尿酸血症与全因死亡和糖尿病相关死亡风险升高相关,部分可能归因于未控制糖尿病高血糖的促尿酸排泄效应(反向因果)。

研究设计与样本

  • 基于1988-1994年和1999-2008年NHANES数据,纳入41807名美国成人,分析血尿酸水平与全因及病因特异性死亡的关系。
  • 计算多变量风险比(HR),男性以血尿酸5-6 mg/dl为参照,女性以5-6 mg/dl为参照。

主要发现

  • 男性血尿酸<4 mg/dl者全因死亡风险升高28%(HR 1.28,95%CI 1.13-1.45)。
  • 男性血尿酸<4 mg/dl者糖尿病相关死亡风险近乎三倍(HR 2.89,95%CI 1.59-5.23),其他特定病因死亡未见增加。
  • 女性血尿酸<3 mg/dl者全因死亡风险未见升高(HR 1.09,95%CI 0.92-1.28)。

关键数值与推荐

  • 男性血尿酸分组:<4、4-5、6-7、7-8、>8 mg/dl,参照5-6 mg/dl。
  • 女性血尿酸分组:<3、3-4、4-5、6-7、>7 mg/dl,参照5-6 mg/dl。

临床怎么用

  • 评估男性低尿酸血症(<4 mg/dl)时应关注全因死亡及糖尿病相关死亡风险。
  • 女性血尿酸低至<3 mg/dl未显示长期超额死亡风险,临床解读低尿酸血症需考虑性别差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The most recent European Alliance of Associations for Rheumatology (EULAR) recommendations for gout advise against maintaining a serum urate (SU) level of <3 mg/dl for prolonged periods of time. While several Asian cohort studies have shown higher rates of mortality in individuals with extremely low SU levels, data from non-Asian cohort studies are scarce, and the relationship between hypouricemia, cardiovascular risk, and mortality remains unclear. METHODS: Using data collected from the 1988-1994 and 1999-2008 National Health and Nutrition Examination Survey (NHANES), we examined the relationship between SU level and overall and cause-specific mortality in 41,807 adults in the US. We calculated multivariable hazard ratios (HRs) that were compared to a referent SU level of 5-6 mg/dl for SU categories <4, 4-5, 6-7, 7-8, and >8 mg/dl in men and SU categories <3, 3-4, 4-5, 6-7, and >7 mg/dl in women. RESULTS: A higher mortality risk was not observed in women who had an SU level of <3 mg/dl (HR 1.09 [95% confidence interval (95% CI) 0.92-1.28]). A 28% higher mortality risk was observed in men who had an SU level of <4 mg/dl (HR 1.28 [95% CI 1.13-1.45]), with a nearly three-times higher mortality risk from diabetes mellitus also noted (HR 2.89 [95% CI 1.59-5.23]), but no increase in mortality from any other specific cause. CONCLUSION: We found no long-term excess mortality risk among American women with SU levels as low as <3 mg/dl, a finding which is incompatible with the notion of a causal relationship between hypouricemia and premature mortality in women. We found excess all-cause mortality and diabetes mellitus-related mortality among hypouricemic American men, which may in part be attributable to the uricosuric effect of hyperglycemia in fatal uncontrolled diabetes mellitus (analogous to reverse causality).

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. D'Silva KM, Yokose C, Lu N, et al. Hypouricemia and Mortality Risk in the US General Population. Arthritis Care Res (Hoboken). 2021. PMID: 33026684. doi:10.1002/acr.24476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。